Table 5.
Authors | Study design | Age | Sex M: F | Previous treatment | Intervention | Pt had surgery | Final analysis | Level of study |
---|---|---|---|---|---|---|---|---|
Chan et al. [21] | Case series retrospective | 37.2 (24–58) | 26:4 | Yes | HVIGI 10 mL 0.5% bupivacaine 25 mg hydrocortisone 4 × 10 ml of normal saline |
0 | 21 | IV |
Humphrey et al. [22] | Case series prospective | 43.5 ± 11.6 | 7:4 | Yes | HVIGI 10 mL 0.5% bupivacaine 25 mg hydrocortisone 4 × 10 mL normal saline |
0 | 11 | IV |
Maffulli et al. [20] | Case series prospective | 37.5 (2263) | 69:25 | Yes | HVIGI 10 ml 0.25% bupivacaine 62,500 U aprotinin |
8 | 87 | IV |
Wheeler et al. [23] | Case series retrospective two groups | 50.6 ± 11.3 | 14:20 | Yes | Group 1: 10 ml 1% lidocaine +40 ml N/saline HVIGI Group 2: dry needling + HVIGI. 10 ml 1% lidocaine +20 ml N/saline |
Group 1:3 Group 2:6 |
34 | III. |